FDA Inspection 1069078 — Algunas Inc., dba Woodland Hills Compounding Pharmacy
The FDA completed an inspection of Algunas Inc., dba Woodland Hills Compounding Pharmacy on October 11, 2018 in Woodland Hills, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 11, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Woodland Hills, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 21377 | FDCA 501(a)(2)(A) | Use of non-pharmaceutical grade components |